ArticleiScience2026
Ectopic overproduction of cell wall glucan through membrane perturbation by an antifungal peptide theonellamide A in fission yeast.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ergosterol has multiple functions in filamentous fungi and yeasts, although only a part of the functions seems to be understood. An antifungal peptide, theonellamide A (TNM-A) induces drastic morphological changes in fission yeast by targeting plasma membrane ergosterol. TNM-A induces overproduction and accumulation of cell wall glucan at growing tips and septum through a yet unknown mechanism. Here, we show that TNM-A causes accumulation of 1,3-β-glucan at cell-polarity sites, not by increased activity of 1,3-β-glucan synthase, but by an increased, persistent localization of the glucan synthases. Screening based on subcellular localization of proteins suggested the involvement of the Rho family GTPase Cdc42, a master regulator of cell polarity. In agreement, TNM-A increased active Cdc42 and enhanced the membrane trafficking of glucan synthases. In conclusion, our chemical genetics analyses using TNM-A suggest that membrane ergosterol regulates the Cdc42 activity, which further regulates the localization of glucan synthases and cell wall biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.